Dysregulated Tim-3 expression and its correlation with imbalanced CD4 helper T cell function in ulcerative colitis

Dysregulated Tim-3 expression and its correlation with imbalanced CD4 helper T cell function in ulcerative colitis

Copyright © 2012 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 145(2012), 3 vom: 21. Dez., Seite 230-40
1. Verfasser: Shi, Fengmin (VerfasserIn)
Weitere Verfasser: Guo, Xiaoqin, Jiang, Xingwei, Zhou, Ping, Xiao, Yan, Zhou, Tingting, Chen, Guojiang, Zhao, Zhi, Xiao, He, Hou, Chunmei, Li, Xinying, Yang, Xiaomei, Wang, Renxi, Feng, Jiannan, Shen, Beifen, Li, Yan, Han, Gencheng
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2012
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Antibodies, Monoclonal CXCL10 protein, human CXCL9 protein, human Chemokine CXCL10 Chemokine CXCL9 Cxcl10 protein, mouse Cxcl9 protein, mouse Galectins mehr... HAVCR2 protein, human Havcr2 protein, mouse Hepatitis A Virus Cellular Receptor 2 Interleukin-17 LGALS9 protein, human Ligands Membrane Proteins RNA, Messenger Receptors, Virus galectin 9, mouse
LEADER 01000naa a22002652 4500
001 NLM222290145
003 DE-627
005 20231224053929.0
007 cr uuu---uuuuu
008 231224s2012 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2012.09.001  |2 doi 
028 5 2 |a pubmed24n0741.xml 
035 |a (DE-627)NLM222290145 
035 |a (NLM)23117395 
035 |a (PII)S1521-6616(12)00225-2 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Shi, Fengmin  |e verfasserin  |4 aut 
245 1 0 |a Dysregulated Tim-3 expression and its correlation with imbalanced CD4 helper T cell function in ulcerative colitis 
264 1 |c 2012 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 17.01.2013 
500 |a Date Revised 25.11.2016 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2012 Elsevier Inc. All rights reserved. 
520 |a The pathogenesis of ulcerative colitis (UC) remains largely unclear. Here we found that T-cell Ig mucin-3 (Tim-3) and its ligand, galectin 9 (Gal-9), were significantly decreased in UC patients and in mice with dextran sodium sulfate (DSS)-induced colitis compared to controls. In addition to an enhanced Th17 response and attenuated regulatory T (Treg) cell response, there was also a significantly decreased Th1 response in UC. Levels of the Th1 cell chemokines CXCL9 and CXCL10 were significantly decreased in UC mice, partially explaining the decreased Th1 cell function in UC. Finally, administration of a putative antagonistic anti-Tim-3 antibody or of recombinant Gal-9 significantly exacerbated or attenuated DSS-induced colitis by altering the balance between different Th cell subsets. Our data suggest that a dysregulated Tim-3/Gal-9 pathway may contribute to the pathogenesis of UC. A better understanding of this pathway may shed new light on the pathogenesis of this disease 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Antibodies, Monoclonal  |2 NLM 
650 7 |a CXCL10 protein, human  |2 NLM 
650 7 |a CXCL9 protein, human  |2 NLM 
650 7 |a Chemokine CXCL10  |2 NLM 
650 7 |a Chemokine CXCL9  |2 NLM 
650 7 |a Cxcl10 protein, mouse  |2 NLM 
650 7 |a Cxcl9 protein, mouse  |2 NLM 
650 7 |a Galectins  |2 NLM 
650 7 |a HAVCR2 protein, human  |2 NLM 
650 7 |a Havcr2 protein, mouse  |2 NLM 
650 7 |a Hepatitis A Virus Cellular Receptor 2  |2 NLM 
650 7 |a Interleukin-17  |2 NLM 
650 7 |a LGALS9 protein, human  |2 NLM 
650 7 |a Ligands  |2 NLM 
650 7 |a Membrane Proteins  |2 NLM 
650 7 |a RNA, Messenger  |2 NLM 
650 7 |a Receptors, Virus  |2 NLM 
650 7 |a galectin 9, mouse  |2 NLM 
700 1 |a Guo, Xiaoqin  |e verfasserin  |4 aut 
700 1 |a Jiang, Xingwei  |e verfasserin  |4 aut 
700 1 |a Zhou, Ping  |e verfasserin  |4 aut 
700 1 |a Xiao, Yan  |e verfasserin  |4 aut 
700 1 |a Zhou, Tingting  |e verfasserin  |4 aut 
700 1 |a Chen, Guojiang  |e verfasserin  |4 aut 
700 1 |a Zhao, Zhi  |e verfasserin  |4 aut 
700 1 |a Xiao, He  |e verfasserin  |4 aut 
700 1 |a Hou, Chunmei  |e verfasserin  |4 aut 
700 1 |a Li, Xinying  |e verfasserin  |4 aut 
700 1 |a Yang, Xiaomei  |e verfasserin  |4 aut 
700 1 |a Wang, Renxi  |e verfasserin  |4 aut 
700 1 |a Feng, Jiannan  |e verfasserin  |4 aut 
700 1 |a Shen, Beifen  |e verfasserin  |4 aut 
700 1 |a Li, Yan  |e verfasserin  |4 aut 
700 1 |a Han, Gencheng  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 145(2012), 3 vom: 21. Dez., Seite 230-40  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:145  |g year:2012  |g number:3  |g day:21  |g month:12  |g pages:230-40 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2012.09.001  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 145  |j 2012  |e 3  |b 21  |c 12  |h 230-40